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Abstract: Strains of the food-borne pathogen Listeria (L.) monocytogenes have diverse virulence poten-
tial. This study focused on the virulence of three outbreak strains: the CC1 strain PF49 (serovar 4b)
from a cheese-associated outbreak in Switzerland, the clinical CC2 strain F80594 (serovar 4b), and
strain G6006 (CC3, serovar 1/2a), responsible for a large gastroenteritis outbreak in the USA due
to chocolate milk. We analysed the genomes and characterized the virulence in vitro and in vivo.
Whole-genome sequencing revealed a high conservation of the major virulence genes. Minor devia-
tions of the gene contents were found in the autolysins Ami, Auto, and IspC. Moreover, different
ActA variants were present. Strain PF49 and F80594 showed prolonged survival in the liver of
infected mice. Invasion and intracellular proliferation were similar for all strains, but the CC1 and
CC2 strains showed increased spreading in intestinal epithelial Caco2 cells compared to strain G6006.
Overall, this study revealed long-term survival of serovar 4b strains F80594 and PF49 in the liver
of mice. Future work will be needed to determine the genes and molecular mechanism behind the
long-term survival of L. monocytogenes strains in organs.
Keywords: pathogenicity; whole-genome analysis; prolonged survival
1. Introduction
The Gram-positive bacterium Listeria monocytogenes is the causative agent of listeriosis,
a rare, but severe food-borne infection in humans and animals. In healthy individuals,
listeriosis is usually restricted to a non-invasive self-limited gastroenteritis, which typically
occurs 24 h after ingestion of a large inoculum of bacteria and usually lasts two days [1].
In immunocompromised individuals and elderly, an invasive and systemic infection can
occur within an incubation time of 20 to 30 days with a high mortality rate of 25–30%.
Furthermore, pregnant women and neonates are a high-risk group. Invasive L. monocyto-
genes infection of non-pregnant individuals typically manifests as bacteremia/septicemia
or as central nervous system infection including meningitis, meningoencephalitis and with
lower prevalence also rhombencephalitis and brain abscess [2–4]. In pregnant women,
L. monocytogenes can infect the fetus or unborn, leading to spontaneous abortion or stillbirth.
Neonatal listeriosis may represent as sepsis or meningitis with severe consequences and a
high case fatality of 20% [5].
There is evidence for the difference in the virulence and pathogenic potential of
L. monocytogenes strains [6–8]. L. monocytogenes strains can be grouped into four major
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phylogenetic lineages (I, II, III and IV), and most clinical strains are of phylogenetic lineage
I and II [9]. Of the 13 lineage-related serovars only three, namely 1/2a within lineage
II, and 1/2b and 4b within lineage I, are responsible for the majority of the clinical cases
of human (and animal) listeriosis [10]. Especially, serovar 4b strains cause over 50% of
listeriosis cases worldwide in spite of being much less frequently found in food samples as
compared to strains from serovar 1/2a and b [6,10]. Furthermore, L. monocytogenes strains
can be assigned to multi-locus sequence types, which are grouped into clonal complexes
(CC). Multi-locus sequence typing is based on the sequences of seven housekeeping genes.
Recent advances in Listeria infection biology have shown that certain CCs such as CC1,
CC2, CC4, and CC6 are more frequently associated with clinical cases, whereas others like
CC9 and CC121 are mainly of food-borne origin [6–8,11].
The understanding of the pathophysiology of Listeria infection has made major steps
forward, but there are still new insights to come. After ingestion and survival in the
stomach, L. monocytogenes traverses the intestinal epithelial barriers via goblet cells and
enterocytes into the lamina propria and spreads into the bloodstream through the lymph
nodes to disseminate to the target organs of replication, the liver and spleen [2,12]. In case
L. monocytogenes trespasses the liver barrier, the bacteria shuttle to secondary sites of clinical
manifestation, the placenta, and the central nervous system. An arsenal of virulence factors
mediates the complex pathogenicity of L. monocytogenes among them the internalins InlA
and InlB, which are required for the entry into non-phagocytic cells [12–14]. Subsequent to
the invasion step, L. monocytogenes is temporarily enclosed in a phagocytic vacuole, before
it escapes into the host cell cytoplasm, which is mediated by the listeriolysin O (LLO) and
the phospolipases (PlC) A and B. Once inside the host cell cytosol, L. monocytogenes can
survive, replicate and move to the neighboring cell. The actin-assembly-inducing protein
ActA is essential for intracellular motility and cell-to-cell spread. Additionally, there are
numerous other virulence factors that e.g., hijack cellular processes, modulate the immune
system reach even the eukaryotic nucleus and influence gene expression [12].
One puzzling issue regarding the pathogenicity of L. monocytogenes is the long incu-
bation period of the invasive manifestation in humans and animals, varying from 24 h
in cases showing gastroenteritis to 9 in cases with central nervous system infection and
27.5 days in cases with abortions, respectively [15]. This unusually long incubation period
required for the manifestation of clinical systemic listeriosis implies that L. monocytogenes
might persist in host tissues for extended periods without causing overt clinical signs. In
a recently published paper, Vazquez-Boland and co-workers stipulated the hypothesis
that hypervirulent strains, which survive longer in the liver and the spleen of the host,
have a higher probability of secondary dissemination of the brain and the placenta [16].
Two hypervirulent 4b strains P14 and PF49, both assigned to CC1, were still detectable in
the mouse liver three weeks post infection [16]. P14 was isolated from an adult patient
with central nervous symptoms in Spain, and PF49 is an epidemic strain from a cheese-
associated outbreak in Switzerland [17]. This observation is striking since most mouse
studies have shown that the infection is cleared from the liver seven days post infection,
when a sublethal dose of L. monocytogenes is administrated.
In this work, we follow-up this hypothesis using the serovar 4b strain PF49 (CC1)
for an in-depth characterisation of its virulence properties. PF49 was associated with a
large community-acquired epidemic of invasive listeriosis with a high proportion of brain
infections (79%) [17]. We compared the genome of strain PF49 with strains F80594 (CC2)
and G6006 (CC3). Strain F80594, also serovar 4b, has caused gastrointestinal listeriosis in a
mainly healthy population [18] and strain G6006 (serovar 1/2b) was isolated during a large
outbreak of gastroenteric listeriosis caused by the consumption of a heavily contaminated
milk product [19] (Table 1). We characterized the virulence potential of these listeriosis
strains in intestinal epithelial, hepatocytic, and phagocytic cells. We aimed to mimic the
natural route of infection (translocation across the epithelium, infection of the liver, and
contact with phagocytes in the bloodstream) and determined the pathogenicity in a mouse
infection model. The laboratory isolate EGD was included as a control.
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Table 1. Strain information and epidemiological data.
Strain PF49 F80594 G6006
Source Cheese Stool Milk
Servoar 4b 4b 1/2b
CC (ST) 1 (1) 2 (2) 3 (3)
Origin Canton of Vaud, Switzerland Næstved area, Denmark Illinois, USA
Isolation Year 1986 1995 1994
No. of Cases 122 3 45
Epidemiologic Clone Identified (%) 75 100 92.9
Pregnancy-Associated Cases (%) a 53.3 0 2.2
Non-Pregnant Cases (%) 46.7 100 97.8
Bacteremia (%) 21 33 6.7 b
Central Nerval Symptoms Developed (%) 79 c 0 2.2 b
Diarrhoea (%) 3 100 79
Underlying Diseases (%) 42 d 0 3.3
Infective Dose Estimated (logCFU) 6 Unknown 11
Median of Incubation (days) Unknown 1 <1
Reference [17] [18] [19]
a Neonate (early onset)/mother cases count as one case. b Cases revealed by post-epidemic surveillance. c In the group of adults (n = 57).
d Elderly aged >65 years not included.
2. Materials and Methods
2.1. Bacterial Strains
The strains were stored at −80 ◦C in 20% glycerol phosphate-buffered saline, pH 7.4
(PBS) and grown in brain-heart infusion (BHI, Merck, Darmstadt, Germany) broth or on
agar at 37 ◦C. Inocula for in-vitro and in-vivo studies were prepared from early stationary
phase cultures. Bacteria were harvested by centrifugation, washed in PBS, resuspended in
glycerol-PBS and stored at −80 ◦C in 500 µL aliquots. The exact number of bacteria in the
frozen aliquots was calculated by plate counting.
2.2. DNA Isolation, Genome Sequencing, and Analysis
The L. monocytogenes strains were cultivated under aerobic conditions at 37 ◦C in BHI
with 125 rpm shaking and harvested by centrifugation. The resulting pellet was used for
DNA isolation using the QIAGEN genomic-tip columns and buffers (QIAGEN), follow-
ing the recommendations of the manufacturer. For G6006 and PF49, genome sequencing
was performed using an Illumina GAII genome analyzer at the University of Veterinary
Medicine Vienna, Austria. Sequencing was performed using paired-end sequencing tech-
nology and 100 bp read-length using Illumina standard protocols. For F80594, genome
sequencing was performed using an Illumina HiSeq2000 sequencer at the Campus Science
Support Facilities (CSF) Next-Generation Sequencing unit, Vienna, Austria, using paired-
end sequencing technology and 100 bp read length. Three (F80594) and ten (G6006, PF49)
million reads were used for a de novo assembly using ABySS [20] with a k-mer size of 64.
For G6006, the assembly resulted in 28 contigs (>500 bp) with an average coverage of 319×.
For PF49, the assembly resulted in 26 contigs (>500 bp), for which the average coverage
was 330×. For F80594, the assembly resulted in 24 contigs with an average coverage of
114×. The draft genome sequences of the L. monocytogenes strains were annotated and
analyzed using PATRIC, www.patricbrc.org (accessed on 15 June 2021) [21]. The presence
and absence of key virulence genes was determined using BlastP searches using a list of
95 virulence proteins as recently described [22].
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2.3. Mouse Infection Assays
Groups of female BALB/C mice weighing 18 to 22 g (six per strain and time point,
Charles River) were infected intravenously (iv) with a sublethal dose (5 × 103 CFU) of
L. monocytogenes and the bacterial load in the liver was monitored at time points 3, 5, 7, 10,
12, 14 and 20 days post infection (p.i.). At the specified time points, the mice were humanely
sacrificed by exposing them to carbon dioxide. The liver was aseptically removed and
homogenised in 10 mL PBS, and the number of CFU per organ was determined by standard
plate counting. The mean 50% lethal doses (LD50) were tested using groups of five BALB/C
mice, which were injected with 200 µL suspensions containing 103, 104, 105, 106, and 107
bacteria. The survival was monitored during a 7-day period. The control group was
injected with 200 µL sterile PBS; LD50 values were determined according to the method of
Reed and Muench [23].
2.4. In-Vitro Virulence Assays
Invasiveness, intracellular proliferation, and cell-to-cell spread were determined using
human intestinal epithelial Caco-2, the mouse macrophage-like P388D1, and the mouse
liver TIB-73 cell lines. Cells were cultivated in 24-well dishes (Greiner, Frickenhausen,
Germany) in 1 mL of RPMI 1640 medium supplemented with 2 mM L-glutamine and 10%
heat-inactivated foetal calf (FCS) serum under 5% CO2–95% O2 atmosphere at 37 ◦C. Cells
were seeded in RPMI-complete medium 72 h prior to infection. The medium was changed
24 h before infection. A gentamicin protection assay was used to determine the invasiveness.
Semiconfluent (80%) cell monolayers were infected with a L. monocytogenes suspension
in RPMI at a multiplicity of infection of 20 for 45 min (P388D1 macrophages) and 60 min
(Caco-2 and TIB-73 cells), washed three times with PBS and incubated for 30 min with fresh
RPMI medium supplemented with 25 µg/mL gentamicin (Serva, Heidelberg, Germany) to
kill extracellular bacteria. The cells were washed, lysed by the addition of 1 mL ice-cold
distilled water followed by incubation on ice for 15 min, and the intracellular bacterial
numbers were determined by plate counting using tryptic soy agar. The intracellular
proliferation was determined by calculating the intracellular growth coefficient with the
formula IGC = (CFU6h − CFUinvasion)/CFUinvasion. To measure the cell-to-cell spread,
cells were infected with strains harbouring the plasmid pLSV16gfp-a. Transformation of
L. monocytogenes PF49, F80594, G6006, and EGD was performed as described earlier [24].
The plasmid stability was confirmed for at least 36 h in cell culture medium supplemented
with 7.5 µg tetracycline. Infection was performed as described above and the number of
intracellular bacteria was counted after 6 h. For flow cytometry analysis, Caco-2 cells were
detached from the dishes by incubation with 200 µL of trypsin solution (Trypsin-EDTA;
Gibco Invitrogen Life Tech., Paisley, UK) for 5 min. The cells were then suspended in 1 mL
PBS and transferred into plastic tubes. GFP fluorescence emitted by intracellular bacteria
was measured by flow cytometry using an Epics Elite ESP cell sorter (Coulter, Krefeld,
Germany) and the percentage of positively stained host cells was determined (488 nm line
of an argon ion laser, green light channel: 525/10 nm bandpass filter, counts: 10,000 cells
per sample per run). All experiments were repeated three times.
2.5. Statistics
Statistical analysis was performed using Excel16.0 and SPSS.24 software. The mean
values and standard deviations (SD) were calculated. The Welch-test was used to determine
variance homogeneity. The Tukey-HSD post hoc test (variance homogeneity) was used to
determine significant differences between the IGC and the percentage of GFP positive cells
of the different strains and the number of bacterial load in the liver at the different time
points. p < 0.05 was considered as a statistically significant difference.
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3. Results
3.1. Whole Genome Sequencing
For the 1983–1987 Swiss Vacherin cheese outbreak, the source of strain PF49, one
additional complete genome was available (strain LL195) [25]. Additional to G6006, two
genomes were available from strains of the milk outbreak in Illinois: FSL-R2-503 (G6054)
and FSL-R2-502 (Table 2). The genome sequences of all listeriosis outbreak isolates revealed
typical features of L. monocytogenes genomes. A general overview of the genomic proper-
ties and features is provided in Table 2. None of the strains contained a plasmid except for
strain FSL-F2-502, which harboured a 57 kbp plasmid. The strains harboured between one
and three prophages.
Table 2. General genomic features of L. monocytogenes outbreak strains.
Strain PF49 LL195 * F80594 G6006 FSL-R2-503 * (G6054) FSL-R2-502 *
Outbreak Switzserland Switzserland Denmark Denmark Illinois, USA Illinois, USA
Source cheese human fecal milk human food
Year 1986 1987 1995 1994 1994 1994
GenBank Accession No. JADXDN000000000 HF558398 JADXDP000000000 JADXDO000000000 AARR00000000 CP006594; CP006595
Genome Assembly Size 2.918 MKbp 2.904 Mbp 2.991 Mbp 2.988 Mbp 2.991 Mbp 3.034 Mbp
No. Contigs 26 1 24 28 55 2
Plasmid Presence (size) no no no no no yes (57,557 bp)
* Only included in the genome analysis.
The Blast search using 95 L. monocytogenes virulence factors as query sequences,
revealed a high conservation of the majority of virulence factors (same length and an amino
acid identity higher than 90%). Among the major virulence factors, we observed only
differences in the ActA sequence. F80594, G6006, FSL-R2-503 and FSL-R2-502 harboured
an ActA4 variant which is comprised of 604 amino acids, whereas PF49 and LL195 had
an ActA3 variant with 604 amino acids [26] (Table 3). Interestingly, PF49 harboured a
truncated Vip protein (Lmo0320) resulting in 335 amino acids compared to 399 amino acids
in EGD-e. Vip in the other strains had a length of 418 amino acids. G6006 and the other
outbreak strains harboured the aut gene, encoding Auto, an autolysin which is important
for L. monocytogenes virulence [27]. In contrast, Auto is absent from F80594 and PF49,
which instead harbored IspC, another autolysin primarily found in serovar 4b strains [28].
Another notable difference between the strains studied here were different variants of Ami,
an additional autolysin encoded by the lmo2588 gene [29,30]. G6006 encodes a full-length
homolog of the EGD-e Ami consisting of 917 amino acids and sharing 99% amino acid
identity, whereas F80954 and PF49 encoded a shorter version of Ami with 770 amino acids
with 72% amino acid identity to the EGD-e Ami. The shorter Ami variants are due to a
lower number of C-terminal GW repeats. Moreover, all strains harboured an Internalin J
(InlJ1) variant, and the listeriolysin S locus was present in all strains except strain F80594.
The additional outbreak strain genomes showed the same genetic features as the
isolates included in the in-vitro and in-vivo assays with a few exceptions: there are possible
truncations in InlJ and GtcA in LL195 compared to PF49 and a 57 kbp plasmid is only
present in FSL-F2-502.
3.2. Animal Behaviour, Recovery of L. monocytogenes from the Liver and LD50
The behaviour of the mice was monitored visually daily post infection. Mice of groups
infected with strain PF49, F80594, and EGD became apathetic three to five days after infection,
displaying shaggy fur and reduced mobility. Upon day 5, all mice infected with these L.
monocytogenes strains returned to normal behaviour. In contrast to the other strains, the mice
infected with strain G6006 remained healthy throughout the observation period.
The two 4b strains, PF49 and F80594, showed different bacterial load patterns in the
liver than strain G6006 and EGD (Figure 1).
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Table 3. Virulence-related genomic features of L. monocytogenes outbreak strains PF49, F80594 and G6006 included in this
study. Other sequenced outbreak related strains (for the Swiss outbreak: LL195; the US outbreak: FSL-R2_503, FSL-R2-502)
were analysed in addition. Amino acid (AA) identities are only shown when lower than 90%.
Protein (Locus_tag) PF49 LL195 * F80594 G6006 FSL-R2-503 (G6054) * FSL-R2-502 *








72% AA identity present (917 AA) absent present (917 AA)
Autolysin Auto
(Lmo1076) absent absent absent present present present
Autolysin IspC
(LMOf2365_1093) present present present absent absent absent
Bacteriocin
















S locus (LIPI-3) present present absent present present present
Vip (Lmo0320) truncated (335 AA) present (418 AA) present (418 AA) present (418 AA) present (418 AA) present (418 AA)
* Only included in genome analysis.




Figure 1. In-vivo pathogenicity. Bacterial loads (log CFU) in the livers of BALB/C mice (n = 6) intra-
venously infected with strain PF49 ((A), circle), F80594 ((B), square), G6066 ((C), rhombus) and EGD 
((D), triangle) 3, 5, 7, 10, 12, 14 and 20 days post infection (p.i.). 
3.3. Invasiveness, Intracellular Proliferation, and Spreading in Host Cells 
To get insights into the invasiveness, intracellular proliferation, and spreading, we 
performed in-vitro assays. 
No difference in the invasion efficiency of all four strains (PF49, F80594, G6006, and 
EGD) was observed in Caco-2 and TIB-73 cells. Furthermore, the uptake of all strains by 
macrophage-like P388-D1 cells was equal (data not shown). In Caco-2 a higher intracellu-
lar proliferation (calculated as IGC) of strain G6006 and EGD was observed compared to 
strain PF49 and F80594; however, the effect was not statistically significant (Figure 2A). In 
contrast, a significantly higher number of GFP-positive Caco-2 cells were observed after 
infection with strain PF49 and F80594 (37.1 and 23.6%) compared to strain G6006 and EGD 
(7.5 and 3.8%, Figure 2B). In TIB-73 cells, no differences between the strains were observed 
for intracellular growth and cell-to-cell spread (Figure 2C,D). In macrophage-like P388D1 
Figure 1. In-vivo pathogenicity. Bacterial loads (log CFU) in the livers of BALB/C mice (n = 6)
intravenously infected with strain PF49 ((A), circle), F80594 ((B), square), G6066 ((C), rhombus) and
EGD ((D), triangle) 3, 5, 7, 10, 12, 14 and 20 days post infection (p.i.).
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On day three (acute infection phase), infecting mice with strain PF49 resulted in a
significantly higher bacterial load in the liver than with strain G6006 and EGD. On day 5,
the bacterial load of mice infected with strain G6006 was significantly lower compared to
the other three strains. PF49 and F80594 were still recovered at day 5 from the liver of all six
animals in high numbers, whereas strain G6006 was only recovered from the livers of two
animals in low numbers. At subsequent time points, strain G6006 was no longer detectable
in the liver. Strain EGD was found at day 7 in the liver of six animals in low numbers.
At later time points, EGD was not recovered from the liver. In contrast, strains PF49 and
F80594 were still detectable in the liver up to day 20 and 14 p.i., respectively. These results
demonstrate that PF49 and F80594 have an enhanced capacity to survive in vivo in the
liver. Furthermore, the LD50 of strain G6006 and EGD (log CFU 5.83 ± 0 and 5.07 ± 0.3)
was higher compared to strain PF49 and F80594 (log CFU 4.620 ± 0 and 4.66 ± 0.2).
3.3. Invasiveness, Intracellular Proliferation, and Spreading in Host Cells
To get insights into the invasiveness, intracellular proliferation, and spreading, we
performed in-vitro assays.
No difference in the invasion efficiency of all four strains (PF49, F80594, G6006, and
EGD) was observed in Caco-2 and TIB-73 cells. Furthermore, the uptake of all strains by
macrophage-like P388-D1 cells was equal (data not shown). In Caco-2 a higher intracellular
proliferation (calculated as IGC) of strain G6006 and EGD was observed compared to strain
PF49 and F80594; however, the effect was not statistically significant (Figure 2A). In contrast,
a significantly higher number of GFP-positive Caco-2 cells were observed after infection
with strain PF49 and F80594 (37.1 and 23.6%) compared to strain G6006 and EGD (7.5
and 3.8%, Figure 2B). In TIB-73 cells, no differences between the strains were observed for
intracellular growth and cell-to-cell spread (Figure 2C,D). In macrophage-like P388D1 cells,
the IGC was lower for strain G6006 and EGD than for strain PF49 and F80594. However,
the differences were only small and not significant. In contrast, an increased cell-to-cell
spread was observed for strain EGD compared to the epidemic strains (Figure 2E,F).
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, e c bi e e e a alysis it i itr ir le ce assays a se
i f ti experiments for up to 20 days to unravel the pathogenicity of outbreak-associated
L. monocytogenes strains. This study is thought to creat some hypotheses why lineage 1
outbreak clones of serovar 4b might have led to a clinical outc me that was obviously ver
different from outbreaks of non-serovar 4b isolates. It further provides a hypothesis why
some Listeria monocytogenes strains tend to persist in the murine body what was proven for
PF49 and P14 [16].
The CC1 strain PF49 is an interesting isolate. Although the esti ated infective dose
was lower in the outbreak associated with PF49 than in the outbreak caused by G6006
(log CFU of 6 for strain PF49 and log CFU of 11 for strain G6006), the Swiss outbreak
was remarkably severe [17,19]. A high percentage of meningoencephalitis cases was also
recorded in the group of non-immunocompromised individuals what was not explain-
able [17]. The low LD50 value and the virulence properties proved PF49 to be a true
hypervirulent isolate. This is in accordance with the findings of other studies that CC1 is
overrepresented among clinical and epidemic strains, often isolated from patients with
fever and no immunocompromising comorbidities [6–8]. Moreover, CC1 strains seem to be
strongly associated with dairy products [31], which is consistent with the finding that soft
cheese was the source of PF49. In contrast, the 4b strain F80594 was isolated from a small
outbreak in a day-care facility in Denmark, in which three children (all of age two) were
involved. The clinical manifestations were vomiting and fever. L. monocytogenes could be
isolated from the blood of one patient [18]. The outcomes of the epidemiological follow-up
investigations were limited. Neither an estimate of the ingested dose nor the exact food
source are available. The isolate F80594 was assigned to CC2. Strains of CC2 were, like CC1
strains, more frequently isolated from clinical than from food-associated sources [6,11,32].
Moreover, CC2 strains are more frequently isolated from dairy than from meat and fish
products [11,31]. The 1/2b serovar strain G6006 is assigned to CC3, an intermediate CC
showing equal distribution among clinical and food isolates [6,31]. G6006 was responsible
for a large outbreak of febrile gastroenteritis due to contaminated chocolate milk in the
United States, including only one case with central nervous symptoms [19]. CC3 does not
seem to be associated with a specific food type [11,31].
We detected differences in the colonization and clearance of the liver, and in the
spreading capacity. In the mouse experiment, we detected that strains PF49 and F80494
showed significantly different colonization and clearance of the liver compared to strain
G6006 and strain EGD. In line with the different clinical manifestations, the highest bacterial
load was found in mice infected with strain PF49, followed by strain F80494 [17,18]. Genetic
differences in virulence-associated genes between the two 4b strains, with an average
nucleotide identity of 99.6%, were rare. PF49 harboured a different ActA variant than
strains F80594 and G6006. F80594 and G6006 had an ActA4 variant, which is slightly longer
than the ActA variant of strain PF49 and EGDe [26]. ActA is responsible for bacterial
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movement and cell-to-cell spread. Moreover, it has recently been shown to be also involved
in aggregation as well as long-term colonization of the gut [33,34]. The effect of the different
ActA variants on the virulence potential and pathogenicity of L. monocytogenes is not well
understood. We can only speculate that the ActA3 variant of strain PF49 might cause the
higher bacterial load at day three due to longer colonization of the gut.
Strains G6006 and EGD revealed lower bacterial loads in the liver at day three post
infection, further decreasing at the following time points. This is the expected behaviour of
L. monocytogenes in the liver of intravenously infected naïve wild-type mice. Clearance of
strain G6006 was faster than that of strain EGD. On day seven, no bacteria were detectable in
the liver. The decrease in the bacterial numbers is a consequence of an effective macrophage
activation and protective immune response mediated by Th1 and CD8+ T-cells [35,36]. In
contrast, bacteria were recovered from the liver of mice infected with the two 4b strains, up
to day 14 for F80494 and day 20 for PF49, respectively. We speculate that some clones might
escape the immune defence, thus leading to a more deferred style of infection. In addition
to PF49, this phenomenon was found also in the CC1 strain P14, isolated from a patient
with CNS manifestation during an outbreak in Spain [37]. Both 4b strains showed higher
spreading in human intestinal epithelial Caco2 cells compared to strain G6066 and the lab
strain EGD. However, these effects were only minor. Spreading in the mouse liver TIB-37
and macrophage-like PD388D1 cells was similar between the three outbreak strains. Only
strain EGD showed significantly higher spreading capacities in the macrophage-like cells.
No differences in the invasion efficiency, uptake by macrophage-like cells, and intracellular
growth were observed.
For the sequence analysis, we have used a set of 95 L. monocytogenes virulence genes
as query sequences for BlastP to identify virulence gene differences among the outbreak
clones. As almost all of the major virulence genes were found highly similar to the reference
sequences (>90% amino acid identity), we infer that the observed differences in virulence
might be either due to posttranscriptional effects or unstudied metabolic pathways. How-
ever, some small differences in the virulence associated genes were observed. Notable is the
presence/absence of the autolysins: IspC, known to be important for virulence [28], is only
present in the two 4b strains, whereas G6006 harboured the autolysin Auto (Lmo1076). It
has been speculated that IspC could be responsible for crossing the blood-brain barrier [28],
which might contribute to the high percentage of central nervous system complications in
the Swiss cheese outbreak. It is currently unclear if the presence of IspC might result in
higher virulence in 4b strains, since Auto also has a role in virulence in L. monocytogenes [27].
Another genomic feature that might explain the difference in virulence in mice between
the strains might be differences in the autolysin Ami, which is important for adhesion and
internalization [29,30]. G6006 harbours an Ami homolog with high similarity (99% amino
acid identity) and the same length (917 amino acids) as the functionally characterized
EGD-e Ami. Interestingly, the Ami homologs in F80594 and PF49 are shorter (770 amino
acids) and show lower amino acid identity (72%) to the EGD-e Ami. The lab strain EGD
showed comparable virulence to G6006 in mice and similar spreading in Caco2 cells and
Ami and Auto were most similar to that of G6006. Future studies are needed to identify
the function and the virulence potential of the different autolysin homologs.
In this study, we showed that not only strains of CC1 [16], but also of CC2 have the
potential to survive for extended time periods in the liver, enhancing the possibility for
dissemination to the secondary organs. Experiments, e.g., transcriptome analysis of bacteria
isolated from organs such as the liver, are needed to determine the molecular mechanism
behind the long-term survival of some L. monocytogenes strains in this tissue. Additional
studies including both a higher number of highly prevalent CCs overrepresented by clinical
and epidemic strains and more strains per CC will be necessary to prove whether the higher
pathogenicity and severe clinical manifestation is due to a prolonged survival capacity in
the intestine, lymph nodes, liver, and spleen.
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